These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10294523)

  • 1. Drug probe expected to have modest impact.
    Tokarski C
    Mod Healthc; 1989 Sep; 19(35):4. PubMed ID: 10294523
    [No Abstract]   [Full Text] [Related]  

  • 2. Perspectives. FDA scandal: white hats, black hats, gray areas.
    Wiener JO
    Faulkner Grays Med Health; 1989 Dec; 43(48):suppl 6 p.. PubMed ID: 10296081
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA takes action against firms in scandal over generic products.
    Pollner F
    Med World News; 1989 Sep; 30(17):14-5. PubMed ID: 10294736
    [No Abstract]   [Full Text] [Related]  

  • 4. Bolar agrees to guilty plea in generic drug probe.
    Wagner M
    Mod Healthc; 1991 Mar; 21(9):17. PubMed ID: 10109180
    [No Abstract]   [Full Text] [Related]  

  • 5. Major events during the generic drug investigations.
    Am Pharm; 1990 Jul; NS30(7):38-9. PubMed ID: 2363392
    [No Abstract]   [Full Text] [Related]  

  • 6. Generics still a favorite Rx for savings.
    Wagner M
    Mod Healthc; 1990 May; 20(21):26-8, 30, 32-3. PubMed ID: 10104890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicine's "gray market"': why alarm bells are ringing.
    Gest T; Lanier LK
    US News World Rep; 1985 Dec; 99(23):52. PubMed ID: 10274713
    [No Abstract]   [Full Text] [Related]  

  • 8. Look out for number one. Illegal practices in the "ethical" medical supply industry.
    Strelnick H
    Health PAC Bull; 1983; 14(2):7-14. PubMed ID: 10261773
    [No Abstract]   [Full Text] [Related]  

  • 9. Remarks at the Food and Drug Law Institute's 48th Annual Conference.
    Niedelman SM
    Food Drug Law J; 2005; 60(2):117-26. PubMed ID: 16097089
    [No Abstract]   [Full Text] [Related]  

  • 10. Groups adapt to generic drug probe with buying strategies.
    Perry PA
    Hosp Mater Manage; 1989 Oct; 14(10):1, 14-5. PubMed ID: 10324694
    [No Abstract]   [Full Text] [Related]  

  • 11. Deterring the importation of counterfeit pharmaceutical products.
    Stearn DW
    Food Drug Law J; 2004; 59(4):537-61. PubMed ID: 15875351
    [No Abstract]   [Full Text] [Related]  

  • 12. SmithKline settles charges of kickbacks at 3 labs.
    Burda D
    Mod Healthc; 1989 Dec; 19(52):3. PubMed ID: 10304218
    [No Abstract]   [Full Text] [Related]  

  • 13. Healthcare industry "anxiously" awaits new Medicare fraud and abuse regulations.
    Robey PE; Valiant C
    Group Pract J; 1988; 37(4):62, 64. PubMed ID: 10302622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposition to therapeutic interchange.
    Mossinghoff GJ
    Am J Hosp Pharm; 1988 May; 45(5):1065. PubMed ID: 3400646
    [No Abstract]   [Full Text] [Related]  

  • 15. Fraud, waste, and abuse in the Medicare pacemaker industry: a report from Congress.
    Caring; 1987 Feb; 6(2):12-20. PubMed ID: 10301438
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug selection concerns more than rhetoric.
    McGregor T
    Am Pharm; 1988 Mar; NS28(3):6. PubMed ID: 3369347
    [No Abstract]   [Full Text] [Related]  

  • 17. Generic drugs: cutting cost, not corners.
    Rados B
    FDA Consum; 1985 Oct; 19(8):26, 28-9. PubMed ID: 10311663
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA action spurs change in groups' drug programs.
    Perry PA
    Hosp Mater Manage; 1989 Nov; 14(11):1, 13-4. PubMed ID: 10295911
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug costs can be defended.
    Lee AM
    Med Mark Media; 1982 Mar; 17(3):36, 38, 40 passim. PubMed ID: 10309584
    [No Abstract]   [Full Text] [Related]  

  • 20. Dismissal of investor fraud claim over HIV drug reversed.
    AIDS Policy Law; 2008 Nov; 23(12):8. PubMed ID: 19145698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.